Oestrogen plus progestin (Oest + Prog) v placebo for the composite end point of coronary heart disease (CHD) death or nonfatal myocardial infarction in postmenopausal women with CHD†
| Events/1000 person y | ||||
|---|---|---|---|---|
| Follow up | Oest + Prog | Placebo | Adjusted relative hazard (95% CI)‡ | NNT |
| †Abbreviations defined in glossary. | ||||
| ‡Relative hazard calculated using a Cox proportional hazards model with intention to treat analyses and adjusted for some demographic and baseline characteristics. | ||||
| 4.1 y | 34.0 | 34.3 | 0.96 (0.78 to 1.18) | Not significant |
| 4.1–6.8 y | 41.8 | 42.1 | 0.98 (0.75 to 1.22) | Not significant |
| 6.8 y | 36.6 | 36.8 | 0.97 (0.82 to 1.14) | Not significant |